Genomic & Biopharma News

US licenses first drug for rare spinal disorder
US regulators recently approved the first therapy to treat spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement.
PharmaTimes, 2017-01-04 11:03:26

Millions of UK asthma patients not receiving basic care
Millions of patients with asthma in the UK are not getting the basic care essential to controlling their condition and preventing related deaths, warns a new report by Asthma UK.
PharmaTimes, 2017-01-04 10:59:32

NICE backs Amicus’ Galafold for Fabry disease
The National Institute for Health and Care Excellence is backing National Health Service use of Amicus Therapeutics' Galafold for treating the rare genetic disorder Fabry disease.
PharmaTimes, 2017-01-04 10:49:05

RNA-Seq Links Severe PMS to Gene Network Disturbance
from Genetic Engineering News – Even though its causes have been unclear, premenstrual dysphoric disorder (PMDD) has been described as a severe form of premenstrual syndrome (PMS). Affecting 2–5% of women of reproductive age, PMDD is like PMS in that it follows a predictable, cyclic pattern. Yet PMDD, which is marked by disabling irritability, sadness, ...
Transcriptome Research & Industry News, 2017-01-04 10:00:58

Researchers describe the first use of spherical nucleic acids as nanoparticle platform for regulating lncRNAs in cells
Emerging evidence indicates that long noncoding RNAs (lncRNAs) are actively involved in a number of developmental and tumorigenic processes. Here, Northwestern University researchers describe the first successful use of spherical nucleic acids as an effective nanoparticle platform for regulating lncRNAs in cells; specifically, for the targeted knockdown of the nuclear-retained metastasis associated lung adenocarcinoma transcript ...
lncRNA Research and Industry News, 2017-01-04 10:00:16

Long-Sought ‘Attack’ Signal in Type 1 Diabetes Identified
In Type 1 Diabetes, the immune system attacks the beta cells, the insulin producing cells that reside in the islets of Langerhans region of the pancreas from Live Science by Tia Ghose – In people with type 1 diabetes, the body wages a ruthless campaign of destruction against certain cells in the pancreas because it ...
Exosome RNA Research & Industry News, 2017-01-04 10:00:14

Braeburn eyes $150M IPO to launch opioid addiction tech
Braeburn eyes $150M IPO to launch opioid addiction tech nick.paul.taylor Wed, 01/04/2017 - 04:34
Fierce Biotech, 2017-01-04 09:34:09

Depressive patients with co-occurring panic disorder report more antidepressant side effects
Patients who take medication for depression report more side effects if they also suffer from panic disorder, according to a new study led by researchers from the University of Illinois at Chicago published in the Journal of Clinical Psychiatry.
News Medical Life Sciences, 2017-01-04 09:15:38

Vitamin D deficiency linked to increased risk of chronic headache
Vitamin D deficiency may increase the risk of chronic headache, according to a new study from the University of Eastern Finland.
News Medical Life Sciences, 2017-01-04 09:08:48